Children born with congenital heart defects may require frequent surgeries that prevent them from living their lives to the fullest. PolyVascular provides the only non-surgical pulmonary valve and delivery system suitable for children as young as 2 years old. Our minimally invasive valve reduces the need for open heart surgery and enables kids to enjoy a healthy, normal lifestyle. Current animal tissue valves often cause endocarditis, while human tissue grafts may sensitize the child's immune system. We address these limitations with our biocompatible, durable, polymer-based valve. Our valve, provided with an-easy-to-use delivery system for clinicians, is easy to manufacture at any size.

Biotechnology

Health Care

Life Sciences

Medical Devices

PolyVascular

Tim Moran

Mary Bales

Steven Girouard

Cindy Clague

Henri Justino

Daniel Harrington

PolyVascular

Org chart

Teams

Similar companies